FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2

FDA Reissues LumiraDx Fast Lab Solutions' EUA for SARS CoV-2 RNA STAR Complete Molecular Reagents to Allow High Throughput and Asymptomatic Testing Solutions

/PRNewswire/ -- LumiraDx (Nasdaq: LMDX) announced today that the intended use for its Food and Drug Administration (FDA) Emergency Use Authorization (EUA)...

Related Keywords

United Kingdom , Sanjay Malkani , Fast Lab Network , Fast Lab Solutions , Lumiradx Fast Lab Solutions , Lumiradx Fastlab Solutions , Fastlab Solutions , Federal Food , Cosmetic Act , Lumiradx Platform , Lumiradx ,